{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T07:11:48Z","timestamp":1714374708150},"reference-count":18,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1111\/j.1439-0507.2009.01726.x","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T04:12:19Z","timestamp":1243570339000},"source":"Crossref","is-referenced-by-count":8,"title":["Onychomycosis in psoriatic patients - rationalization of systemic treatment"],"prefix":"10.1111","author":[{"given":"Avner","family":"Shemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Trau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batya","family":"Davidovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo H.","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz","family":"Amichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(18)30876-3","article-title":"Psoriasis of the nail","volume":"3","author":"Scher","year":"1985","journal-title":"Dermatol Clinic"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.1997.tb03673.x","article-title":"A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study","volume":"136","author":"Gupta","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","article-title":"Psoriatic nails: a prospective clinical study","volume":"7","author":"Salomon","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2230.1986.tb00439.x","article-title":"Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects","volume":"11","author":"Baran","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2230.2007.02568.x","article-title":"Prevalence of fungal involvement in series of patients with nail psoriasis","volume":"33","author":"S\u00e1nchez-Rega\u00f1a","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1439-0507.2007.01405.x","article-title":"Do fungi play role in psoriatic nails?","volume":"50","author":"Szepietowski","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2340\/00015555-0323","article-title":"Increased prevalence of onychomycosis among psoriatic patients in Israel","volume":"88","author":"Leibovici","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2133.1976.tb05171.x","article-title":"Nails and fungi","volume":"94","author":"English","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.2008.08805.x","article-title":"New criteria for the laboratory diagnosis of nondermatophyte moulds in onychomycosis","volume":"160","author":"Shemer","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB10","first-page":"683","article-title":"Etancercept in the treatment and retreatment of psoriasis in daily clinical practice","volume":"18","author":"Barrera","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baselone nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1\u2003year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB12","first-page":"217","article-title":"Treatment of nail psoriasis with efalizumab: a preliminary study","volume":"82","author":"Lamerson","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1468-3083.2006.01698.x","article-title":"Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus","volume":"20","author":"Gupta","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","article-title":"The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life","volume":"41","author":"Drake","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","article-title":"Antifungal agents","volume":"187","author":"Chen","year":"2007","journal-title":"Med J Aust"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/000155599750010364","article-title":"Inverse psoriasis induced by terbinafine","volume":"79","author":"Pauluzzi","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB17","first-page":"17","article-title":"Terbinafine exacerbates psoriasis: case report with a literature review","volume":"11","author":"Szepietowski","year":"2003","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1111\/j.1439-0507.2009.01726.x-BIB18","first-page":"1","article-title":"The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial","volume":"32","author":"Ka\u00e7ar","year":"2007","journal-title":"Clin Exp Dermatol"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2009.01726.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1439-0507.2009.01726.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T03:59:09Z","timestamp":1625630349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2009.01726.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2009.01726.x","relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}